Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
PharmaMar is a Spanish biopharmaceutical company headquartered in Madrid, specializing in the research, development, and commercialization of novel anti-tumor drugs of marine origin. With a strong focus on oncology, PharmaMar has successfully brought to market treatments like Yondelis® (trabectedin) for soft tissue sarcoma and ovarian cancer, and Zepzelca® (lurbinectedin) for metastatic small cell lung cancer. The company's unique approach leverages the biodiversity of the ocean to identify and develop compounds with therapeutic potential, managing an extensive marine organism library. PharmaMar has a robust pipeline of drug candidates and strategic partnerships to expand its reach globally.
The headquarters serves as the primary center for PharmaMar's global operations, including cutting-edge research and development in marine-derived compounds, drug discovery, preclinical and clinical development, corporate strategy, and administrative functions.
The facility houses state-of-the-art laboratories for molecular biology, cell culture, chemical synthesis, and pharmacology. It also includes specialized infrastructure for the collection, identification, and analysis of marine organisms, forming the core of their unique drug discovery platform.
PharmaMar fosters a highly scientific and innovative work environment, encouraging collaboration among multidisciplinary teams of biologists, chemists, pharmacologists, and clinicians. There's a strong emphasis on research excellence and a shared mission to combat cancer.
This location is pivotal as it underpins PharmaMar's entire value chain, from the initial discovery of active compounds in marine organisms to the advanced stages of drug development and coordination of global commercialization efforts.
PharmaMar supports its global operations through a network of subsidiaries and strategic partnerships. Core functions like research and development are centralized in Spain, while commercialization, medical affairs, and clinical trial management are conducted through its offices in key markets like the USA, Italy, France, Germany, UK, Switzerland, Austria, Belgium and Portugal. Additionally, PharmaMar collaborates with partners to market its products in regions where it doesn't have a direct presence, ensuring broader patient access to its innovative marine-derived oncology treatments worldwide.
Avda. de los Reyes, 1, PolĂgono Industrial La Mina-Norte
Colmenar Viejo
Madrid
Spain
Address: PharmaMar USA Inc., 510 Madison Avenue, Suite 405, New York, NY 10022
To expand market access and drive sales of PharmaMar's oncology drugs in the significant US market, manage relationships with key opinion leaders and healthcare providers, and support ongoing clinical development programs in the region.
Address: PharmaMar S.r.l., Via G. Spadolini 7 - Centro Leoni, Edificio B - 4° Piano, 20141 Milan
To ensure successful commercialization and patient access to PharmaMar's therapies in Italy, engaging with local healthcare systems, regulatory bodies, and medical professionals.
Address: PharmaMar SAS, 48 Boulevard des Batignolles, 75017 Paris
To strengthen PharmaMar's presence in France, facilitate access to its innovative cancer treatments, and support local clinical research initiatives.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, PharmaMar' leadership includes:
PharmaMar has been backed by several prominent investors over the years, including:
PharmaMar has seen some key appointments and transitions in its leadership, particularly strengthening its US operations. The core C-suite team in Spain has remained largely stable.
Discover the tools PharmaMar uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
PharmaMar typically utilizes standard corporate email formats. The most common patterns involve combinations of the employee's first name, last name, or initials followed by '@pharmamar.com'.
[first_initial][last]@pharmamar.com (e.g., jsmith@pharmamar.com) or [first].[last]@pharmamar.com (e.g., john.smith@pharmamar.com)
Format
asmith@pharmamar.com
Example
80%
Success rate
PharmaMar Official Website / Press Release • May 28, 2024
PharmaMar presented new data on Zepzelca® (lurbinectedin) for the treatment of small cell lung cancer (SCLC) during the American Society of Clinical Oncology (ASCO) Annual Meeting. The presentations included results from a retrospective observational study and a Phase I/II trial in combination therapy....more
PharmaMar Official Website / Press Release • April 26, 2024
PharmaMar reported total revenues of €35.1 million in Q1 2024, with a net profit of €0.2 million. Recurring revenues, including net sales of goods and royalties, were €26.9 million, a decrease attributed to lower Zepzelca® sales in the US compared to the previous year....more
PharmaMar Official Website / Press Release • March 1, 2024
PharmaMar announced a net profit of €1.1 million for the full year 2023, with total revenues reaching €157.7 million. The company highlighted its R&D investment of €61.5 million and progress in its clinical pipeline....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including PharmaMar, are just a search away.